Halsey Associates’s Amgen AMGN Stock Holding History

Halsey Associates’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,118	Closed	-$218K	–	109
2018 Q4	$218K	Hold	1,118	–	–	0.04%	95
2018 Q3	$232K	Buy	+1,118	New	+$220K	0.04%	93

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Halsey Associates's AMGN Position: Q1 2019 in Review

Halsey Associates sold out of Amgen (AMGN) in Q1 2019, closing a stake of 1,118 shares — an estimated $218K sold.

Halsey Associates first reported a position in AMGN in Q3 2018 and held it in 2 quarters. The position peaked at $232K in Q3 2018. 1,887 funds tracked by Wall St. Rank hold AMGN as of Q1 2019.

Halsey Associates reported no remaining Amgen position as of Q1 2019 after selling out during the quarter.
Halsey Associates sold 1,118 Amgen shares in Q1 2019, an estimated $218K.
Halsey Associates first reported a position in Amgen in Q3 2018 and held it in 2 quarters.
Halsey Associates's Amgen position peaked at $232K in Q3 2018.
1,887 funds tracked by Wall St. Rank held Amgen as of Q1 2019.

Based on Halsey Associates's 13F filing for Q1 2019, filed 15 May 2019.